We've found
8,147
archived clinical trials in
Asthma
We've found
8,147
archived clinical trials in
Asthma
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Click here to add this to my saved trials
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Updated: 1/31/2013
A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma
Status: Enrolling
Updated: 1/31/2013
Click here to add this to my saved trials
Study of Bronchodilation Effects of Cetirizine
Updated: 2/4/2013
Assessment of Bronchodilatory Effects of Cetirizine in Adults With Concomitant Allergic Rhinitis and Mild Asthma as Measured by Impulse Oscillometry.
Status: Enrolling
Updated: 2/4/2013
Study of Bronchodilation Effects of Cetirizine
Updated: 2/4/2013
Assessment of Bronchodilatory Effects of Cetirizine in Adults With Concomitant Allergic Rhinitis and Mild Asthma as Measured by Impulse Oscillometry.
Status: Enrolling
Updated: 2/4/2013
Click here to add this to my saved trials
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
Click here to add this to my saved trials
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
Click here to add this to my saved trials
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
Click here to add this to my saved trials
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
Click here to add this to my saved trials
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
Click here to add this to my saved trials
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
Click here to add this to my saved trials
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
Click here to add this to my saved trials
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
Click here to add this to my saved trials
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
Click here to add this to my saved trials
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
Click here to add this to my saved trials
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
Click here to add this to my saved trials
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
Click here to add this to my saved trials
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
Click here to add this to my saved trials
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
Click here to add this to my saved trials
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
Click here to add this to my saved trials
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
Click here to add this to my saved trials
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
Click here to add this to my saved trials
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
Click here to add this to my saved trials
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
Click here to add this to my saved trials
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
Click here to add this to my saved trials
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
Click here to add this to my saved trials
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
Click here to add this to my saved trials
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
Click here to add this to my saved trials
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
A Study of ARRY-502 in Patients With Persistent Asthma
Status: Enrolling
Updated: 2/12/2013
Updated: 2/12/2013
Click here to add this to my saved trials